Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 701–800 of 1,000
Akın, D. F., & Özkan, D. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.09.010 · Cited by 8
Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer
Dimitrova, P. D., Vasileva‐Slaveva, M., Shivarov, V. S., Hasan, I., & Yordanov, A. D. (2023) · Medicina · doi:10.3390/medicina59040728 · Cited by 8
“Macrophages are part of innate immunity, and through their ability to process and present antigens to produce cytokines necessary for T-lymphocyte activation, they are critical for initiating and mediating specific IR as well [14].”
BackgroundSong, C., Wu, C., Lin, C., Tsai, C., Chen, H., Fong, Y., Chen, L., & Tang, C. (2024) · Environmental Toxicology · doi:10.1002/tox.24236 · Cited by 9
“14 However, M2-type macrophages augment the production of arginase-1, which can induce tumor growth, and generate anti-inflammatory cytokines, including IL-10.”
BackgroundMyeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review)
Kumar, D., Silva, V. D., & Chaves, N. L. (2024) · Medicine International · doi:10.3892/mi.2024.170 · Cited by 9
“Macrophages exhibit heterogeneity, with at least two functionally distinct subtypes responding to different stimuli: classically activated M1 macrophages and alternatively activated M2 macro‑ phages (69).”
BackgroundNotch signaling and cancer: Insights into chemoresistance, immune evasion, and immunotherapy
Saadh, M. J., Omar, T. M., Ballal, S., Mahdi, M. S., Chahar, M., Verma, R., Al-Hussein, R. K. A., Adil, M., Jawad, M. J., & AL-Nuaimi, A. M. A. (2025) · Gene · doi:10.1016/j.gene.2025.149461 · Cited by 8
Wang, T., McElroy, A., Halaney, D. L., Vela, D. C., Fung, E., Hossain, S., Phipps, J. E., Wang, B., Yin, B., Feldman, M. D., et al. (2015) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22366 · Cited by 9
“, breast, prostate, ovarian, cervical, and cutaneous melanoma) [55].”
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
Marcucci, F., & Rumio, C. (2021) · Cells · doi:10.3390/cells10040872 · Cited by 8
“IFN-γ stands out as the best known [81,102,112], but also other inflammatory cytokines like TNF-α, IL-6 and IL-1β have been shown to upregulate ICPMLs [113].”
BackgroundPrognostic Role of Receptor Tyrosine Kinase–Like Orphan Receptors in Intestinal-Type Gastric Cancer
Nema, R., Patel, P., & Kumar, A. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.7.2125 · Cited by 9
Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
Meyiah, A., Alahdal, M., & Elkord, E. (2023) · iScience · doi:10.1016/j.isci.2023.106333 · Cited by 8
“Several studies demonstrated the crucial role of M2-TAMs in the pathogenesis of GIC.(15) The link between the increasing number of M2-TAMs in GIC and poor prognosis has been extensively studied.”
BackgroundInfluentialXaplanteri, P., Rodis, N., & Potsios, C. (2023) · Microorganisms · doi:10.3390/microorganisms11051203 · Cited by 9
“The equilibrium of the healing process is dependent on the perfect functioning and cooperation of M2 subpopulations [2,10,13,14].”
BackgroundKatzenback, B. A., Foroutanpay, B. V., & Belosevic, M. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.019 · Cited by 9
“This represents an important area of study, particularly for cancer biology in which cancerous cells often create a immunosuppressive environment, often including M2 polarized cells as a mechanism of immune evasion, reviewed by (Hao et al., 2012).”
BackgroundChang, H.-W., Lin, Z.-M., Wu, M.-J., Wang, L., Chow, Y., Jiang, S. S., Ch’ang, H.-J., & Chang, V. H. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175586 · Cited by 8
“Recently, it was also reported that TAMs interact with cancer stem cells, which facilitate tumorigenicity, metastasis, and drug resistance [24].”
Spassov, S. G., Faller, S., Hummel, M., Helo, K., Ihle, A., Ryter, S. W., Strosing, K. M., & Hoetzel, A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002440 · Cited by 8
Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
Lu, Y., Gu, D., Zhao, C., Sun, Y., Li, W., He, L., Wang, X., Kou, Z., Jiang, S., & Guo, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160052 · Cited by 9
“Macrophages in the immune environment of most cancer cells act as M2 phenotype and express var ious ant i - inflammatory molecules , l ead ing to an immunosuppressive microenvironment (56).”
BackgroundP2 purinergic receptor expression and function in tumor-related immune cells
Manoharan, V., Adegbayi, O. O., & Maynard, J. P. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10054-7 · Cited by 9
“TAMs secrete chemokines, cytokines, and growth factors that promote macrophage infiltration and tumor progression [53].”
Xue, Z., Zhang, X., Mao, B., Mu, G., Zhang, Y., Liu, J., Zhao, J., Liu, X., Sun, Y., Xiang, G., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf075 · Cited by 9
Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer
Ghorbaninezhad, F., Vanan, A. G., Rostami, S. M., Vaezi, F., Doachi, R., Hafshejani, Z. A., Ehteshaminia, Y., Nouri, M., Mohammadi, N. G., talebileili, M., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04017-0 · Cited by 7
“M2 macrophages are characterized by high expression of arginase-1 and IL-10 and contribute to angiogenesis, invasion, and metastasis through the secretion of various chemokines and growth factors [82–84].”
Anchan, M. M., & Dutta, R. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70179 · Cited by 7
“Both circumstances involve pro-angiogenic, immunosuppressive, and pro-angiogenic M2 macrophages that suppress cytotoxic immunity and promote stromal remodeling and neovascularization [143, 144].”
Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs
Jung, M., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053096 · Cited by 7
Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors
Melwani, P. K., Checker, R., Balla, M. M. S., & Pandey, B. N. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-65944-7_8 · Cited by 9
Mathews, L., Appukuttan, D., Victor, D. J., Venkadassalapathy, S., Subramanian, S., & Prakash, P. S. G. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.111214 · Cited by 7
CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
Lezhnin, Y. N., Khristichenko, A. Y., Ratnikova, N. M., Kravchenko, Y. E., & Chumakov, S. P. (2018) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2018-3-313-340 · Cited by 7
IL-15 and GM-CSF stimulated macrophages enhances phagocytic activity in ENU induced leukemic mice
Singha, A. K., Sarkar, C., Majumder, D., Debnath, R., Saha, M., & Maiti, D. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.12.003 · Cited by 7
Macrophages — a perspective target for antineoplastic immunotherapy
Karaman, О. М., Ivanchenko, A. V., & Chekhun, V. F. (2019) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-41-no-4.13698 · Cited by 9
Li, J., Zhou, Z., Chu, L., Jiang, X., Xu, J., Wu, L., Zhang, T., Wang, J., Ren, G., Mou, X., et al. (2021) · Journal of Biobased Materials and Bioenergy · doi:10.1166/jbmb.2021.2046 · Cited by 7
Cervical Cancer Outcome and Tumor-Associated Macrophages: Research Evidence
Horta, B., Pereira, T., Medeiros, R., & Cerqueira, F. (2022) · Immuno · doi:10.3390/immuno2030028 · Cited by 8
Makhani, K., Yang, X., Dierick, F., Subramaniam, N., Gagnon, N., Ebrahimian, T., Lehoux, S., Wu, H., Ding, J., & Mann, K. K. (2025) · Environmental Health Perspectives · doi:10.1289/ehp14285 · Cited by 8
Sakaguchi, M., Fukumoto, T., Fujishima, F., Fukuda, K., Kozaru, T., Ban, M., & Oka, M. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13910 · Cited by 7
Low periostin expression predicts poor survival in intestinal type gastric cancer patients
Zhang, T., Han, Z., Chandoo, A., Huang, X., Sun, X., Ye, L., Hu, C., Xue, X., Huang, Y., Shen, X., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s175596 · Cited by 7
Kumarasinghe, U., Majumder, N., Sutaria, J. M., Luo, Y., Chen, Y., Staii, C., & Kaplan, D. L. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123605 · Cited by 7
Ahamed, C., Nguyen, L., Brock, C. S., Farzamnia, A., Millet, P., Sato, K., & Kumar, K. K. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf193 · Cited by 6
“34 Macrophage polarization is influenced by the molecular components of its surrounding environment dictating whether the macrophage adopts a classically activated phenotype or an alternatively activated phenotype.”
Hammouri, D., Weis, T. A., & Siskind, L. J. (2025) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151672 · Cited by 7
Cao, Y. J., Beeraka, N. M., Efetov, S. K., Liu, Z., Otabekov, A. A., Basappa, B., Wang, W., & Ma, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1623117 · Cited by 6
“MMP11 and Plaur play roles in degrading the extracellular matrix (153, 154), while Ccl7 recruits tumor-associated macrophages, enhancing malignancy (155 – 157).”
Self-citationBahng, I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1713123 · Cited by 6
“Among macrophage subtypes, M2a phenotypes — largely known for their key role in fi brosis, a major element of PDAC desmoplasia, and characterized by their activation via Th2 cytokines IL-4 and IL-13 — seem to be the most relevant in the context of CCL17 and CCL22 upregulation (54 – 57).”
Han, L., Guo, K. X., Gu, F., Zhang, Y., Li, K., Mu, X., Liu, H., Zhou, X., & Luo, W. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5566 · Cited by 6
“Previous studies have demonstrated that TAMs are primarily polarized towards alternatively activated macrophages (9,10) with the markers of CD163, CD301 and CD206 (11,12), which are thought to be closely associated with the angiogenesis, immunosuppression and activation of tumor cells (6).”
BackgroundThe immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules
Zhao, C., Xiao, R., Jin, H., & Li, X. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15380 · Cited by 6
“61,62 cDC induce cellular and humoral immunity by forming MHC I/CD8 or MHC II/CD4 immunological synapses with initial T cells, while pDC produce large amounts of IFN-γ , thereby accelerating innate and adaptive immunity and thus suppressing tumor progression 63 Comparatively, lung tumors also cause…”
BackgroundYe, W., Liang, X., Chen, G., Chen, Q., Zhang, H., Zhang, N., Huang, Y., Cheng, Q., & Chen, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14850 · Cited by 7
“56 Hence, HEC1 may promote the development of glioma by inducing M2 polarization of macrophages via receptor ligands.”
Mirzaei, N. M., Kevrekidis, P. G., & Shahriyari, L. (2024) · Royal Society Open Science · doi:10.1098/rsos.240718 · Cited by 6
“Since these cell types tend to accumulate in hypoxic regions, they quickly adapt to severe hypoxia [50].”
Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer
Murugaiyan, G. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_7 · Cited by 8
“M1 phenotype, which further promotes TGF-β production and deepens immunosuppression [ 126 ].”
BackgroundObesity and Increased Risk for Atherosclerosis and Cancer
Carpi, F. G. A. (2014) · Internal Medicine Open Access · doi:10.4172/2165-8048.1000154 · Cited by 7
“Tumor associated macrophages (TAMs) are termed macrophages in human microenvironments cancer and they can be classified into classical activated M1-like or alternatively activated M2-like macrophages: in the tumor microenvironment TAMs play a role in tumor progression influencing angiogenesis, lymphoangiogenesis, grow…”
BackgroundRenne, M., Conforti, F. S., Camastra, C., Donato, A., & Donato, G. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200120 · Cited by 6
“In breast cancer the majority of tumor-associated macrophages (TAMs) exhibits alternatively activated M2 properties, produces abundant anti-inflammatory factors and facilitates tumor development (4, 6).”
BackgroundHołownia, A., Niechoda, A., Lachowicz, J., Golabiewska, E., & Baranowska, U. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_323 · Cited by 6
Moncla, L.-H. M., Briend, M., Sylla, M. S., Mathieu, S., Rufiange, A., Bossé, Y., & Mathieu, P. (2024) · Communications Medicine · doi:10.1038/s43856-024-00530-x · Cited by 5
“Among these proteins, CSF1 (M-CSF) is a hematopoietic colony-stimulating factor involved in the development of yolk sac macrophages, therenewaloftissueresidentmacrophagesaswellasthepolarizationtowardaM2-likephenotype 69,95 – 97 .”
Dendritic cells pulsed with penetratin-OLFM4 inhibit the growth and metastasis of melanoma in mice
Baek, B.-S., Park, H., Choi, J., Lee, E., Youn, J.-I., & Seong, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117083 · Cited by 5
Xu, Q., Chen, X., Ma, Z., Zhong, H., Feng, G., & Gu, S. (2024) · Liver International · doi:10.1111/liv.16197 · Cited by 5
Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Arroyo-Nogales, A., Plaza-Palomo, G., Gónzalez‐Larre, J., Jiménez‐Falcao, S., & Baeza, A. (2025) · Molecules · doi:10.3390/molecules30061257 · Cited by 5
“…This increased the uptake of silicasomes and exploited the well-known tumoritropic capacity of the macrophages and other phagocytic cells [32], enabling the nanocarrier to reach the tumor site and promoting deep tumor infiltration and distribution. tumor-itropic capacity of the…”
Han, I., Choi, I., Kim, S., Kwon, M., Choi, H.-J., & Bae, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652166 · Cited by 7
“Among the various cellular components of the TME, tumor-associated macrophages (TAMs) have emerged as critical regulators in tumor progression (5).”
A critical guideline for controlling monocyte-derived macrophages phenotypes
Moschetti, G., Oliveri, D., Matteis, V. D., Zaccaria, M., Rondelli, D., Griego, A., Scarpa, E., & Rizzello, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694625 · Cited by 6
The Immunoendocrine Network in Breast Cancer
Castro, K. E. N., Arreola, M. I. P., Ostoa‐Saloma, P., Muñiz‐Hernández, S., Cerbón, M. A., Gómez-Icazbalceta, G., Muñoz-Cruz, S., Aguilar-Díaz, H., Pavón, L., Romero, J. I. C., et al. (2014) · Advances in Neuroimmune Biology · doi:10.3233/nib-140097 · Cited by 5
“Another significant aspect of tumor immunity is the tumor microenvironment, which harbors several chemoattractants, such as IL-4, IL-13, TGF- , and IL10, all of which effect the adoption of an M2 phenotype that can direct the differentiation of macrophages into the M2 phenotype and thus a poor prognosis [93].”
BackgroundBiological implications of the immune factors in the tumour microenvironment of oral cancer
Shetty, S. S., Padam, K. S. R., Hunter, K. D., Kudva, A., & Radhakrishnan, R. A. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105294 · Cited by 6
Kanazawa, T., Ohara, K., Kitamura, Y., Nakaya, M., Yoshida, K., & Sasaki, H. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03855-y · Cited by 5
Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer
Garo, L. P., & Murugaiyan, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_13 · Cited by 6
Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
Zhang, Y., Zhan, L., Li, J., Jiang, X., & Li, Y. (2023) · Aging · doi:10.18632/aging.204679 · Cited by 5
RETRACTED: Pro-inflammatory responses after peptide-based cancer immunotherapy
Mahaki, H., Ravari, H., Kazemzadeh, G., Lotfian, E., Daddost, R. A., Avan, A., Manoochehri, H., Sheykhhasan, M., Mahmoudian, R. A., & Tanzadehpanah, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32249 · Cited by 5
“The TME macrophages demonstrate the characteristic or M1-like phenotype with strong anti-tumor action throughout the early stages of cancer progress and secrete proinflammatory cytokines like TNF-α , IL-6, IL-23, IL-12, and IL-1 β [34].”
BackgroundRetractedYu, M., Niu, Z.-M., & Wei, Y.-Q. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7289 · Cited by 6
“The decrease may be supported by the hypothesis that infiltrated macrophages which could provide an immunosuppressive microenvironment for tumor growth (Hao et al., 2012)would be inhibited in immunized environment to prevent tumor colonization and growth.”
BackgroundComito, G., Segura, C. P., Sobierajska, K., Ippolito, L., Taddei, M. L., Giannoni, E., & Chiarugi, P. (2014) · European Journal of Cancer · doi:10.1016/s0959-8049(14)50278-x · Cited by 5
Hrabák, A., Bőgel, G., Murányi, J., Tamási, V., Németh, K., Szokol, B., Kukor, Z., Kardon, T., & Őrfi, L. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.11.002 · Cited by 6
Mojsilović, S. S., & Santibanez, J. F. (2015) · Cell Biology International · doi:10.1002/cbin.10435 · Cited by 5
“…TGF-b regulates macrophage behavior favoring polarization towards M2 phenotype, 624 Cell Biol Int 39 (2015) 619–628 © 2015 International Federation for Cell Biology which, in part, mediates immunosuppressive roles of TGF-b (Mantovani and Sica, 2010; Hao et al., 2012; Krstic and Santibanez, 2014).”
BackgroundBelyaev, N. N., & Abramova, V. A. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.019 · Cited by 5
“mor-associated fibroblasts [50], suppressive endothelial cells [51], tumor-associated macrophages [52,53], tolerogenic dendritic”
BackgroundThe Microenvironment in DCIS and Its Role in Disease Progression
Roozitalab, R., Prekete, N., Allen, M. D., Grose, R. P., & Jones, J. L. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_12 · Cited by 4
Wang, M., Zhang, Y., Li, Y., Zhang, M., Liu, J., Cao, Y., Xie, J., & Wang, S. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266337430241127112031 · Cited by 4
Self-citationUsing a systems biology approach to understand and study the mechanisms of metastasis
Ha, N., & Hunter, K. W. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1237 · Cited by 4
Immunosuppressive peculiarities of stromal cells of various kidney tumor types
Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., Алексеевна, П. П., Tabiev, R. M., Kuncevich, N. V., Efremov, G. D., Alekseev, B. Y., & Gratchev, A. N. (2020) · Cancer Urology · doi:10.17650/1726-9776-2020-16-2-29-35 · Cited by 4
Goodin, D. A., & Frieboes, H. B. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111383 · Cited by 6
Puspitarini, S., Azzamudin, H., Ulinnuha, M., Puspitoputri, A. H., Khansa, S., Widyarti, S., Widodo, N., & Rifa’i, M. (2024) · Malaysian Journal of Fundamental and Applied Sciences · doi:10.11113/mjfas.v20n2.3332 · Cited by 4
“M2 macrophages function to remove dead cells, repair damaged tissue, encourage the development of new blood vessels, and support tumor development [10].”
BackgroundRole of tumor associated macrophages in regulating pancreatic cancer progression
Caso, R., & Miller, G. (2016) · World Journal of Immunology · doi:10.5411/wji.v6.i1.9 · Cited by 4
Bijarchian, F., Taghiyar, L., Azhradi, Z., & Eslaminejad, M. B. (2021) · PubMed Central · doi:10.22038/ijbms.2021.57887.12870 · Cited by 4
“M1 macrophages express pro-inflammatory molecules such as IL-23, IL-12, TNF-α, and major histocompatibility classes I and II (MHCI/ II)(21).”
BackgroundTNF-TNFR1 Signaling Enhances the Protection Against Neospora caninum Infection
França, F. B. F., Silva, M. V., Silva, M. F., Ramos, E. L. P., Miranda, V. D. S., Mota, C. M., Santiago, F. M., Mineo, J. R., & Mineo, T. W. P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.789398 · Cited by 12
Paramanantham, Y., Chung, I., & Said, N. A. B. M. (2022) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2022.01.013 · Cited by 5
Cancer Immunoediting: Immunosurveillance, Immune Equilibrium, and Immune Escape
Bhatia, A., & Kumar, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_16 · Cited by 4
Bondoc, A., Golbar, H. M., Pervin, M., Katou-Ichikawa, C., Tanaka, M., Izawa, T., Kuwamura, M., & Yamate, J. (2017) · Cancer Microenvironment · doi:10.1007/s12307-017-0193-x · Cited by 4
“ent anti-tumor properties, through amplification of the immune responses [4].”
BackgroundInfluentialPolarization of Tumor Milieu: Therapeutic Implications
Szala, S., Jarosz–Biej, M., Cichoń, T., Smolarczyk, R., & Sochanik, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_22 · Cited by 4
“, TNF-α, IL-1, IL-6, IL-12, and IL-23) [ 14 ].”
BackgroundInfluentialZhang, Y., Feng, J., Fu, H., Liu, C., Yu, Z., Sun, Y., She, X., Li, P., Zhao, C., Liu, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00934 · Cited by 4
Lu, L., Li, W., Peng, C., Chen, L., He, X., Shao, C., Wang, C., & Ge, R. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00582-7 · Cited by 3
“They express a series of cytokines, chemokines, tumor growth, metastasis, and immuno-suppression [46].”
BackgroundWang, M., Yang, X., Zhang, Q., Qiu, Y., Qu, J., Xu, H., & Li, Q. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157325 · Cited by 5
Sui, M., Xie, K., Luo, Y., Wang, H., Sheng, H., Yue, S., Liu, X., Li, S., Suk, J. S., Chen, S., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03749-5 · Cited by 3
“Current evidence suggests that NP phagocytosis can modulate macrophage polarization, but the direction of polarization (M1 vs. M2) is highly NP-dependent [27– 29].”
Li, Y., Li, Z., Zhao, G., Han, Q., Ding, Z., Wang, C., & Li, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-19764-3 · Cited by 3
“Concurrently, the expression of SLC9A9 (solute carrier family 9 member A9) in tumor-associated macrophages is closely associated with the immunosuppressive microenvironment 58 , thereby enhancing immune escape and promoting the recurrence of head and neck squamous cell carcinoma 59 .”
Cui, L., Zhao, S., Lu, G., Zhang, S., Zhang, R., Zhou, J., & Yao, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115828 · Cited by 3
Ge, L., Guo, H., Zhou, W. J., Shi, W., Yue, J., & Wu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112951 · Cited by 3
Zhu, M., Zhang, S., Tang, J., Hou, H., Wang, L., Lin, H., Zhang, X., & Jin, M. (2025) · Life · doi:10.3390/life15010105 · Cited by 3
Roy, K., Jędrzejewski, T., Sobocińska, J., Spisz, P., Maciejewski, B., Hövelmeyer, N., Passeri, B., & Wrotek, S. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.104934 · Cited by 3
Tootee, A., Nikbin, B., Ghahary, A., Nasli‐Esfahani, E., Arjmand, B., Aghayan, H. R., Qorbani, M., & Larijani, B. A. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210203212809 · Cited by 3
Sharif, P. M., Khoshbin, A. P., Nasrollahzadeh, E., Keshavarz‐Fathi, M., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00003-7 · Cited by 8
An Epic Advancement in Targeting Macrophages for Cancer Therapy Approach
Lu, X., Qiuxia, F., Rui-e, L., Wang, D., Muluh, T. A., & Zhang, Y. (2024) · Current Drug Delivery · doi:10.2174/0115672018299798240403062508 · Cited by 3
Innate and Adaptive Immune Responses to Cancer
Hastings, K. T., & Rausch, M. P. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_4 · Cited by 3
Zhang, P., Jin, Y., Zhang, Q., Yi-ming, W., Wu, W., Yao, W., Wu, Y., Li, Z., Zhao, Y. X., Liu, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.4871 · Cited by 4
Advances in pancreatic cancer stem cells, tumor-associated macrophages, and their interplay
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.304 · Cited by 4
Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute Pancreatitis
Miller, K. J., Raulefs, S., Kong, B., Steiger, K., Regel, I., Gewies, A., Kleeff, J. H., & Michalski, C. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143735 · Cited by 3
“During inflammation, macrophages support the clearance of the destroyed tissue through phagocytosis of damaged and dead cells [21] and promote regeneration by supporting the resolution of inflammation, tissue renewal and angiogenesis [22, 23].”
BackgroundPerisé-Barrios, A. J., Serramía, M. J., de la Mata, J., Gómez, R., Corbí, A. L., Domínguez‐Soto, Á., & Muñoz‐Fernández, M. Á. (2015) · RSC Advances · doi:10.1039/c5ra20623e · Cited by 3
Models of Experimental Sporotrichosis and Immune Response Against Sporothrix schenckii
Carlos, I. Z., Ferreira, L. S., & Gonçalves, A. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-11912-0_7 · Cited by 5
Arkhipov, S. A., Михайлова, Е. С., Кунц, Т. А., Карпухина, К. В., Mogilnaya, E., Solovyev, K. A., Анатольевич, В. Н., & Autenshlyus, A. I. (2016) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2016-5-459-468 · Cited by 3
Gong, F., Zhang, Y., Lin, J., Li, C., Zhou, C., Hong, P., Ryu, B., & Qian, Z. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5639486 · Cited by 3
“Tumor is the abnormal growth of tissue and the formation of mass [1].”
BackgroundPorphyromonas gingivalis in Periodontitis: A Forgotten Enemy Behind COVID-19 Pandemic
Utomo, H., Wijaksana, I. K. E., & Prаhаsаnti, C. (2021) · Dental Hypotheses · doi:10.4103/denthyp.denthyp_95_20 · Cited by 5
Szegvári, G., Dóra, D., & Lohinai, Z. (2023) · Biology · doi:10.3390/biology12030376 · Cited by 4
“Exploring perturbations that represent therapeutic action, we show the effect of single and combinatory inhibitions of crucial protein targets in the signal transduction of macrophage polarization in a presumptive TME.”
BackgroundInfluentialCo-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies
Kim, E., Fortoul, M. C., Weimer, D., Meggyesy, M. A., & Beckler, M. D. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105027 · Cited by 4
Hiller, J. G., Parat, M., & Ben‐Eliyahu, S. (2015) · Current anesthesiology reports · doi:10.1007/s40140-015-0113-x · Cited by 3
Notch Signaling Mediates Tumor-CAF Crosstalk in Basal-like Breast Cancer
Song, J. (2014) · TSpace (University of Toronto) · Cited by 3
Chiu, Y., Ni, C., & Huang, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.6197 · Cited by 2
Tumor-Associated Macrophages and Their Role in Cancer Progression and Treatment Strategies
Ibarra, L. E., Bühler, E. M., & Cesca, B. A. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_307 · Cited by 2
Suman, S., Nevala, W. K., Leontovich, A. A., Jakub, J. W., Geng, L., McLaughlin, S. A., & Markovic, S. N. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1522717 · Cited by 2
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.